74 days to either accept or reject. Once interim COVID-19 trial results are released and the spotlight is on Cytodyn, HIV BLA rejection without extremely good cause would blow up in the FDA's face. The last thing the FDA wants is an investigation into how the FDA held back a no SAE, no resistance HIV drug for years.